Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis
Bone immunity regulates osteoclast differentiation and bone resorption and is a potential target for the treatment of postmenopausal osteoporosis (PMOP). The molecular network between bone metabolism and the immune system is complex. However, the molecular mechanism underlying the involvement of the...
Main Authors: | Xiaoning Wang, Xin Zhang, Yidan Han, Xinwei Duan, Jianchang Wang, Hui Yan, Shanshan Wang, Yunteng Xu, Zaishi Zhu, Lili Wang, Yanfeng Huang, Qing Lin, Xue Tan, Junkuan Zhuo, Haifeng Zhang, Min Mao, Weiying Gou, Zhouping Yi, Xihai Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.876067/full |
Similar Items
-
Major histocompatibility complex genomic investigation of endangered Chinese alligator provides insights into the evolution of tetrapod major histocompatibility complex and survival of critically bottlenecked species
by: Ke He, et al.
Published: (2022-12-01) -
Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
by: Hideki Ikeda, MD, et al.
Published: (2023-10-01) -
The role of melatonin in the development of postmenopausal osteoporosis
by: Keda Yang, et al.
Published: (2022-10-01) -
OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01) -
Potential mechanism of tea for treating osteoporosis, osteoarthritis, and rheumatoid arthritis
by: Xinyu Xie, et al.
Published: (2024-02-01)